Matches in Harvard for { <http://id.lib.harvard.edu/aleph/009309452/catalog> ?p ?o. }
Showing items 1 to 37 of
37
with 100 items per page.
- catalog abstract "A behind-the-scenes profile of biotech company ImClone profiles Sam Waksal as a charismatic opportunist who led cancer patients to believe that a breakthrough treatment was imminent, citing the contributions of key investors, researchers, and business affiliates.".
- catalog contributor b13142448.
- catalog created "c2004.".
- catalog date "2004".
- catalog date "c2004.".
- catalog dateCopyrighted "c2004.".
- catalog description "A behind-the-scenes profile of biotech company ImClone profiles Sam Waksal as a charismatic opportunist who led cancer patients to believe that a breakthrough treatment was imminent, citing the contributions of key investors, researchers, and business affiliates.".
- catalog description "Includes bibliographical references and index.".
- catalog description "The $2 billion antibody. Cancer cells are smart ; The idea of the new ; Family business ; The "miracle" -- Small and one armed ; A very high-risk opportunity ; The $2 billion antibody -- Refusal to file. The letter ; "We screwed up" -- Clinical trial. Inquiries ; The disconnect that wouldn't go away -- Who knew what and when? ; Coincidences piling up ; In the light of October -- The once and future miracle drug. Art, death, and taxes ; Icarian actions.".
- catalog extent "xviii, 412 p. ;".
- catalog identifier "0060555564 (alk. paper)".
- catalog issued "2004".
- catalog issued "c2004.".
- catalog language "eng".
- catalog publisher "New York : HarperBusiness,".
- catalog spatial "United States".
- catalog spatial "United States.".
- catalog subject "2004 B-544".
- catalog subject "338.7/61616994061/092 B 22".
- catalog subject "Antibodies, Monoclonal economics United States.".
- catalog subject "Antineoplastic Agents economics United States.".
- catalog subject "Antineoplastic agents industry Corrupt practices United States.".
- catalog subject "Biotechnology economics United States.".
- catalog subject "Businessmen United States Biography.".
- catalog subject "Cancer Chemotherapy.".
- catalog subject "Drugs United States Testing.".
- catalog subject "Ethics, Business United States History.".
- catalog subject "HD9675.A672 W35 2004".
- catalog subject "ImClone Systems Incorporated History.".
- catalog subject "ImClone Systems Incorporated.".
- catalog subject "Insider trading in securities United States.".
- catalog subject "Monoclonal antibodies Research United States History.".
- catalog subject "QV 269 P971c 2004".
- catalog subject "Waksal, Samuel David.".
- catalog tableOfContents "The $2 billion antibody. Cancer cells are smart ; The idea of the new ; Family business ; The "miracle" -- Small and one armed ; A very high-risk opportunity ; The $2 billion antibody -- Refusal to file. The letter ; "We screwed up" -- Clinical trial. Inquiries ; The disconnect that wouldn't go away -- Who knew what and when? ; Coincidences piling up ; In the light of October -- The once and future miracle drug. Art, death, and taxes ; Icarian actions.".
- catalog title "The cell game : Sam Waksal's fast money and false promises--and the fate of ImClone's cancer drug / Alex Prud'homme.".
- catalog type "text".